PACE DIAGNOSTICS

Monrovia, CA · Founded 2017 · Medtech · Private

Point-of-care urine tuberculosis antigen rapid detection test using functionalized superparamagnetic nanoparticles and lateral flow assay

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
Monrovia, CA
Founded
2017
Latest Form D
$1.6M, Mar 2018
Total capital
$1.9M
Federal grants
$300K
1 award · 2025
Rank in peer group#12 of 542
Private capital raised
$1.6M
1 Form D · last Mar 2018
104 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
3 pending

Capital timeline

20182019202020212022202320242025FEDERAL ↑EQUITY ↓Cumulative $1.9M$300K1st Form D$1.6M
2018202020222024FEDERAL ↑EQUITY ↓Cumulative $1.9M$300K1st Form D$1.6M

Latest events

  • Federal grantHealth and Human S · Phase I · An Ultrasensitive Urine TB Antigen Rapid Detection Test for the Diagnosis of Active Tuberculosis$300K
  • Private capital raisedForm D · SEC · 1st filing$1.6M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 542 peers

Line = median

Medtech · Device

  • Federal grants#12 · top 2%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Hiep-Hoa Anthony T. NguyenResearcherExecutive Officer, DirectorLinked by $300K in grants as PI
  • Lorne T. MattnerExecutive Officer, DirectorNamed in SEC Form D filings
  • Marianne T. NguyenDirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 3
  • PendingMycobacterium Tuberculosis Proteins In Diagnostic Assays And Devices For Tuberculosis Detection And DiagnosisUSPTOApplication 19074333
  • PendingMycobacterium Tuberculosis Proteins In Diagnostic Assays And Devices For Tuberculosis Detection And DiagnosisUSPTOApplication 16336022
  • PendingMycobacterium Tuberculosis Proteins In Diagnostic Assays And Devices For Tuberclusis Detection And DiagnosisUSPTOApplication PCTUS2017063154
  • Intabio, Inc.Similar federal contract value in Medtech · null in contracts
  • Injectsense, Inc.Similar federal contract value in Medtech · null in contracts
  • ASTRIN BIOSCIENCES, INC.Similar federal contract value in Medtech · null in contracts
  • Spark Neuro Inc.Similar federal contract value in Medtech · null in contracts
  • ELM TREE MEDICAL INC.Similar federal contract value in Medtech · null in contracts
  • IFIT PROSTHETICS, LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .